Sacred Heart University

DigitalCommons@SHU
DNP Projects

Dr. Susan L. Davis, R.N. and Richard J. Henley
College of Nursing

5-2022

Decreasing Time to Antibiotic Administration in Febrile
Neutropenic Adult Oncology Patients in the Emergency
Department: An Evidence-Based Quality Improvement Project
Kristin Murray

Follow this and additional works at: https://digitalcommons.sacredheart.edu/dnp_projects
Part of the Emergency Medicine Commons, Medical Pharmacology Commons, Oncology Commons,
and the Quality Improvement Commons

Recommended Citation
Murray, K. (2022). Decreasing time to antibiotic administration in febrile neutropenic adult oncology
patients in the emergency department: An evidence-based quality improvement project [Unpublished DNP
project]. Sacred Heart University.

This DNP Project is brought to you for free and open access by the Dr. Susan L. Davis, R.N. and Richard J. Henley
College of Nursing at DigitalCommons@SHU. It has been accepted for inclusion in DNP Projects by an authorized
administrator of DigitalCommons@SHU. For more information, please contact ferribyp@sacredheart.edu,
lysobeyb@sacredheart.edu.

1

Decreasing Time to Antibiotic Administration in Febrile Neutropenic Adult Oncology
Patients in the Emergency Department: An Evidence-Based Quality Improvement Project

Kristin Murray, BSN, RN

A DNP project submitted in partial fulfillment
of the requirements for the degree of
Doctor of Nursing Practice

DNP Project Faculty Advisor: Joan O’Rourke, DNP, MBA, RN
DNP Project Mentor: Marilyn Omabegho, MSN, RN, NE-BC

Sacred Heart University
Davis & Henley College of Nursing
May 2022

2

This is to certify that the DNP Project Final Report by

Kristin Murray

has been approved by the DNP Project Team on

April 13, 2022

for the Doctor of Nursing Practice degree

DNP Project Faculty Advisor: Joan O’Rourke, DNP, MBA, RN
Practice Mentor: Marilyn Omabegho, MSN, RN, NE-BC

3
Acknowledgements
I would like to acknowledge the following people who were instrumental in supporting my
achievements over the years:
•

My family and friends who listened and inspired me through the difficult times and
celebrated every small victory. I could not have done this without you all by my side,
especially, Mom, Dad, and Andrew.

•

My project mentor, Marilyn Omabegho, who has watched my nursing career grow from
day one.

•

The entire ED staff for their cooperation toward my project’s success.

•

Dr. O’Rourke for her guidance through every stage of the project, her encouragement,
and commitment to excellence.

•

My DNP cohort and all the SHU faculty for all the lessons and valuable input.

4
Abstract
Introduction—Significance and Background: Febrile Neutropenia (FN) is the most common
and serious complication of hematopoietic cancers and in patients receiving chemotherapy.
Patients in this immunocompromised state have weakened immunity to fight off infection and a
mortality rate of almost 10%. Thus, Infectious Diseases Society of America has identified the
single most important determining factor of outcomes is the timing of antibiotic (TTA)
administration and has identified the gold standard to be 60 minutes. Current practice does not
follow guidelines and the current policy does not address the urgency of antibiotic
administration.
Purpose: The purpose of this project is to improve the care of FN patients by administering
antibiotics within one hour of identification of neutropenia.
Interventions and Setting: The focus of this project occurred in the emergency department
(ED) of a 230-bed acute care hospital, affiliated with a large healthcare system, located in
Somerville, NJ. The population of focus was adult oncology patients presenting with a chief
complaint of fever and subsequently found to be neutropenic. Using keywords from the PICO
search question, a literature review was conducted using the following databases: CINAHL
Complete, Cochrane Database of Systematic Reviews, MEDLINE, and Proquest. From the
evidence search, a total of five articles fit the criteria for review that had a focus of timing of
antibiotic administration. ED staff nurses were educated on FN using evidence-based practice, in
alignment with the Institute of Medicine goals of providing safe, effective, and timely care.
Evaluation: 88.7% of ED staff nurses were educated on the importance of timely antibiotic
administration. Post-education demonstrated 52.94% of patients received antibiotics within 60
minutes, compared to 17.65%, pre-education. Overall TTA decreased from 6.61 hours to 1.13

5
hours. Hospital length of stay decreased from 7.91 days to 5.8 days; and there were zero ICU
admissions or mortalities post-education.
Discussion: Based on the literature, it is recommended to implement staff education in order to
administer antibiotics within one hour to FN patients. Administering antibiotics within one hour
has proven to decrease length of stay, mortality rates, and ICU admissions.
Key Words: neutropenic fever, febrile neutropenia, length of stay, mortality, antibiotics,
antibiotic timing
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Executive Summary
Febrile neutropenia is a life-threatening complication of cancer treatment that results in
hospitalization and the need for broad spectrum antibiotics. With 50% of deaths in patients
receiving chemotherapy being attributed to febrile neutropenia, prompt recognition and treatment
of this condition reduces the mortality rate to 10%. Prompt recognition and management with
timely administration of antibiotics is lifesaving and cost efficient by reducing the length of stay,
ICU admissions, and mortality.
The goal is to implement an EBP protocol in the Emergency Department that provides
early recognition of neutropenic fever and antibiotic administration within one hour. This
involves inter-professional collaboration and education of ED staff. The vision of implementing
a protocol of timely antibiotic administration is to ultimately work with nursing informatics to
develop an alert in the EMR, similar to sepsis alerts. Risk stratification could influence the
medical management in febrile neutropenic patients.
Current practice and policy do not address the urgency of antibiotic administration in
adult cancer patients. Patients waited over six hours to receive their first dose of antibiotics, had
an average length of stay of nearly 10 days, and a 50% mortality rate. Nursing education greatly
reduced the wait time to the first dose of antibiotics to 1.13 hours, the length of stay to 5.8 days,
and resulted in zero ICU admissions or mortalities.
The literature supports staff education and implementation of streamlined processes.
Administration of antibiotics within one hour has proven to reduce the length of hospital stay,
ICU admission rates, and mortality rates. Policy revision is needed to improve the care of febrile
neutropenic patients. Additionally, built in order sets to the electronic health record triggered by
a pop-up when patients meet certain criteria will expedite proper management.
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Phase 1: Problem Identification and Evidence Review
Background and Significance of Problem
Febrile neutropenia (FN) is the most common and serious complication of hematopoietic
cancers and in patients receiving chemotherapy. FN is a single oral temperature of greater than or
equal to 1010F, or a sustained temperature of 100.40F for one hour, accompanied by an absolute
neutrophil count of less than 1,500 cells/microliter (Punnapuzha et al., 2019). Patients in this
immunocompromised state have weakened immunity to fight off infection and a mortality rate of
almost 10% (Kuderer et al., 2006). Thus, the Infectious Diseases Society of America (IDSA) has
identified the single most important determining factor of outcomes is the timing of antibiotic
administration. This oncologic emergency requires a collaborative interprofessional team
consisting of infectious disease specialists, emergency medicine, oncology, pharmacy, and
specialty-trained nurses for proper management (Punnapuzha et al., 2019).
Description of Local Problem and Organizational Priority
The institution does not currently have a policy (See Appendix A) addressing the urgency
of antibiotic administration in adult cancer patients presenting with a fever to the ED. Treatment
of FN is typically referred to as prompt administration of empiric broad-spectrum antibiotic
therapy, although the definition of prompt remains ambiguous without policies (Koenig et al.,
2019). An evidence-based practice (EBP) quality improvement (QI) project at this hospital

involves benchmark data collection and staff education in order to administer antibiotics within
one hour in FN patients in the ED. This strategy abides by the gold standard of antibiotic
administration within one hour and aligns with the aims set forth by the Institute of Medicine,
including, safe, effective, patient-centered, timely, and efficient care (Agency for Healthcare
Research and Quality, 2018).
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Focused Search Question
The literature was searched for evidence to answer the following clinical question in
PICO format: In adult neutropenic oncology patients (P), does nursing education (I), compared
to no education (C) decrease time to antibiotic administration in the ED (O)?
Evidence Search
External Evidence
Using the PICO search question, a literature review was conducted using the following
databases: CINAHL Complete, Cochrane Database of Systematic Reviews, MEDLINE, and
Proquest. The key words searched were neutropenic fever, febrile neutropenia, length of stay,
mortality, antibiotics, antibiotic timing. Boolean connectors were used as shown in summary
tables B1—B4. Search terms and database results are also displayed in those tables (See
Appendix B). The final search for each database was limited using the following parameters:
English language, all adults, 2010-2020, and full text. Inclusion criteria for article selection
included implementation and improvement of protocols to reduce timing of antibiotics and
impact of timing on patient outcomes.
There is a wealth of evidence from the literature supporting the goal of improving timing
of antibiotic administration in FN patients. Koenig et al. (2019) conducted a systematic review
and meta-analysis to evaluate the association between TTA and patient outcomes in order to

make recommendations for targeted TTA based on the gold standard outlined by the IDSA.
Byuk Sung et al. (2015) studied the impact that timing of antibiotic administration has on the
mortality rate of hospitalized FN patients. The latency of the first dose was an independent factor
associated with serious complications of FN (Byuk Sung et al., 2015).

12
There is strong evidence from other organizations supporting the need for improvement
in the care of FN patients. The Cleveland Clinic implemented a comprehensive protocol to
reduce TTA in adult cancer patients presenting to the ED with a fever. Classifying FN on the
same index severity as myocardial infarction encouraged proper triaging of patients, resulting in
32% of patients receiving antibiotics within one hour compared to the benchmark of 1% (Yu,
2016). Oregon Health and Science University collected baseline data in order to implement a
Plan-Do-Study-Act cycle to reduce time to antibiotics and sustained their improvements through
maintenance efforts including audits and feedback. They achieved their goal of having at least
80% of patients receive antibiotics within one hour (Burns et al., 2019).
Evidence Appraisal, Summary, and Recommendations
A total of five articles fit the criteria for review that had a main focus of timing of
antibiotic administration. These articles were appraised for quality using the Johns Hopkins
Nursing EBP Research Evidence Appraisal Tool and incorporated the Melnyk Level of Evidence
Hierarchy. The evidence summary table (See Appendix C) captures the overall theme that
median antibiotic time of one hour or less improved patient outcomes and subsequently
decreased length of stay. Additionally, studies that included staff education concluded that
implementing streamline processes decreased the TTA. Two of the articles were Level V,
retrospective cohort studies and the other three articles were Level VI, including a QI audit study

and two EBP QI projects (See Appendix D).
Based on the literature, it is recommended to implement staff education in order to
administer antibiotics within one hour to FN patients. Administering antibiotics within one hour
has proven to decrease length of stay, mortality rates, and ICU admissions.
Phase 2: Project Planning
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Project Goals
The main focus of this project is to improve the care of FN oncology patients by
administering antibiotics within one hour of identification of neutropenia using the established
SMART goal method:
1. Specific: Administer antibiotics within 60 minutes of identification of FN;
2. Measurable: Time of arrival to administration;
3. Attainable: 80% of patients will receive first dose within 60 minutes after intervention;
4. Relevant: Aligns with Institute of Medicine goals of providing safe, effective, and timely
care. 60 minutes is the gold standard set forth by the IDSA; and
5. Time-bound: September 2021 intervention; October 2021-December 2021 evaluation.
Framework
Kotter’s Change Theory guided the implementation of this project. The first three stages
of this eight-step theory create a climate for change. Stages four through six engage the
organization and lastly stages seven and eight are useful for implementation and sustaining the
change.
1. Create urgency
2. Form a powerful coalition
3. Create a vision for change

4. Communicate the vision
5. Empower action
6. Create quick wins
7. Build on the change
8. Make it stick
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(Kotter, n.d.).
Context
Description of Setting
The setting of this QI project occurred in a 230-bed acute care hospital located in New
Jersey. The focus of this project occurred in the ED where patients present when acutely ill. The
population of focus is adult oncology patients presenting with a chief complaint of fever and
subsequently found to be neutropenic.
Key Stakeholders
ED staff nurses, ED Nurse Educator, ED Nurse Manager, Marilyn Omabegho, MSN, RN,
OCN, project mentor, Nursing informatics
Practice Change/Intervention
The proposed practice change is a QI project with a pre- and post-test design intervention
(Appendix E). The key stakeholders will be provided with an in-service on the importance of
timely antibiotic administration in FN patients. A pre-test will be provided prior to the education
component of the in-service. Following the education, the same test will be administered to
assess learning outcomes. The goal is to educate at least 80% of ED staff nurses.
Evaluation
Approximately three to six months of baseline data will be collected prior to

administering the pre- and post-test and providing education. The baseline data will include the
number of adult oncology patients who were admitted with a diagnosis of FN. Inclusion criteria
of adult oncology patients includes an absolute neutrophil count less than or equal to 1,500
cells/mm3 and temperature greater than or equal to 100.4F. From that data, it can be determined
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the average wait time to receive the first does of antibiotics. Additionally, length of stay,
mortality, and ICU admission rates data can be determined.
Once the intervention is complete, adherence to administering antibiotics within one hour
will be assessed through chart audits at one month, two months, and three months, post
intervention.
Possible Barriers to Implementation
Resistance to change and lack of awareness on the importance of FN are potential
barriers to successful implementation. Incorporation of Kotter’s Change Theory will help create
an awareness and interest by highlighting the advantages of the EBP project and compatibility
with the Institute of Medicine goals. Linking the practice change to the priorities of the
stakeholders and the organizational mission will enhance commitment to the EBP change in
order to improve patient care. Evidence strongly suggests that implementation of a standardized
protocol improving antibiotic administration timing resulted in a decreased 28-day in-hospital
mortality rate (Hanzelka et al., 2013); and lower mortality rates increase profit margins and
decrease overall costs (Baek et al., 2018). These resources will be influential in obtaining buy-in
from the stakeholders as the first step to implementation.
Sustainment
For the sustainability of this EBP project, nursing informatics will assist with the monthly

data collection of the number of FN patients presenting to the ED, TTA, length of stay, ICU
admission, and mortality rates. The benchmark will be the average time FN patients waited for
the first dose of antibiotics prior to implementation.
Another sustainability strategy involves creating a standing order set in the electronic
health record based on the patient’s condition. There will be a pop-up informing the nurse,
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provider, and pharmacist that the patient has an absolute neutrophil count less than or equal to
1,500 cells/mm3 and a temperature greater than or equal to 100.4oF, so that prompt treatment can
be initiated in accordance with the guidelines set forth by the IDSA (Punnapuzha et al., 2019).
Literature supports the use of order sets as one of the methods to standardize care and improve
outcomes for specific patient populations (Best et al., 2011). Simplifying the process and
improving efficiency is an added benefit of standing order sets (Cullen et al., 2018).
Melnyk and Fineout-Overholt (2019) define the mentor role as an integral part of
sustainability by ensuring the progression of the process is well understood by all point-of-care
providers and administrators. The project mentor and ED educator will identify a champion that
acts in the mentor role capacity. Some of the champion’s duties will include ongoing data
collection and assessment of the QI implementation, and education to peers in order to foster an
EBP behavior through knowledge and skills. The champion will use the data, education, and peer
feedback to identify barriers to best practice and collaborate with the interprofessional team to
overcome such barriers and improve outcomes.
The sustainability process continues to unfold as the champion incorporates the data and
interacts with the involved parties to integrate project work into existing committee
responsibilities. Shared-governance, monthly staff meetings, and committee meetings foster a
spirit of inquiry, which aligns with the sustainability strategy of “culture of improvement and a

deeply engaged staff” (Institute for Healthcare Improvement, 2008). The institution is a magnet
organization, so this phase will reinforce the pride that administration has for their staff
surrounding QI. Additionally, nurses maintain an interest in QI based on the clinical ladder
incentives. All staff will continuously be reminded of opportunities for improvement at
committee meetings.
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Timeline
February-April 2021
• Complete oral and written DNP project proposal presentation
• Present project proposal to SHU faculty and project mentor
• Make revisions as needed
January-May 2021
• Submit Institutional Review Board (IRB) forms to hospital for approval
• Gather baseline and background data
June-September 2021
• Implement project, including pre-test, in-service education, and post-test
October-December 2021

• Gather post-intervention data
January-April 2022
• Analyze date
• Present final DNP project
• Submit final DNP project
Resources
Anticipated resources for this project include:
1. People
•

Patients, stakeholders, IRB board approval, faculty advisor

2. Material
• Educational materials related to the project
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Ethical Merit
Table 1 is a completed QI tool. An answer of yes to all of the items in l-l0 and no to all of
the items in 11-14 indicates that this project meets criteria for a QI project. It also indicates that
the project does not qualify as human subjects’ research and does not have to go through the IRB
at Sacred Heart University.
This QI project abided by the IRB protocols of the institution. An IRB application was
submitted as exempt, as this is a QI project, and no research was conducted on human subjects
and approved as such (Appendix F).
Phase 3: Implementation
Actual Project Implementation
The project implementation did not go as planned. The COVID-19 pandemic was a
contributing factor. There were multiple periods of time in which students were not allowed at
the hospital. These restrictions only allowed for email and telephone communication, which was
difficult at times, due to the demands of the pandemic, especially on the ED, and varying
schedules. It was also difficult obtaining the baseline data from the IT department of the
electronic health record, so there was little leeway in time to complete the education.
Another barrier that led to deviation in the implementation plan was when the hospital
transitioned their electronic health record to a new system. The time of their “go-live” coincided

with the time that the nurses would have been educated using the pre- and post-test in-service
format. After collaborating with the ED nurse educator and ED manager, it was decided that it
would be best to revise the education plan. Both the ED nurse educator and ED manager felt that
the staff nurses could not take on additional requirements with a pre- and post-test in-service.
Instead, the staff were educated on FN and the significance of timely antibiotic administration
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during their safety huddles. The original PowerPoint that was created for the in-service was left
for them in their breakroom. At the safety huddle, each nurse signed in to gather the total number
of nurses that were educated.
Once the education was completed in September 2021, the post-intervention data was
collected from October 2021 through December 2021 from the new electronic health record IT
department.
Deviations From Project Plan
As stated above, the implementation did not go as planned. The nurses were not able to
take the pre- and post-test due to time constraints and changes occurring throughout the
organization. Additionally, the intent was to gather data at one-, two-, and three-month intervals
following the education. However, it was not able to occur due to lag times in communication to
retrieve the data and the transition of electronic health record. This would have allowed for more
real-time trouble shooting to address barriers preventing the improvement in TTA. Furthermore,
the IT department would only release the data to the nursing informatics liaison from the
hospital, who could then relay the information.
Phase 4: Evaluation
Results
The following process measure and subsequent outcome measures were collected before

and after ED staff nurse education:
Process measure
•

Percent of patients who received antibiotics within 60 minutes

Outcome measures
•

Length of hospital stay (LOS)

20
•

Mortality rates

•

ICU admissions

The process measure evaluation determines if the intervention was successful in achieving the
goal, while the outcome measures demonstrate the impact of the practice change.
A total of 62 staff nurses work in the ED. 88.7% of the nurses were educated for this QI
project and their experience can be seen in Table 2. Table 3 represents the process and outcome
measures that were collected before the intervention. The process measures or, percent of
patients who received their first dose of antibiotics within the indicated time frame, is listed as
the first characteristic. The outcome measures are also listed in Table 3, according to how the
TTA affects each individual category. For example, when patients received their antibiotics in
less than 60 minutes, the average LOS was 9.67 days, and the mortality rate and ICU admissions
rates were 0% respectively. Only 3 out of 17 (17.65%) patients from June 2021 to August 2021
received antibiotics within 60 minutes. Conversely, when TTA exceeded 180 minutes in 2 out of
17 (11.76%) patients, 100% of those two patients were admitted to the ICU, and of those
patients, there was a 50% mortality rate. Figure 1 displays the process measure and outcome
measures results, while Figure 2 displays the LOS in relation to the TTA.
Figure 3 and Figure 4 display the process measure and outcome measures results,
respectively, from the post-intervention data that was collected from October 2021 through
December 2021. 52.94% of patients received their first dose of antibiotics under 60 minutes,
representing nearly a 200% improvement; thus, these patients received care in accordance with
the gold standard.
Interpretation
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It can be concluded that when patients receive the first dose of antibiotics within 60
minutes, they have better outcomes. Table 4 displays the process and outcome measures of the
post-intervention data. Over 50% of patients received their first dose of antibiotics in less than 60
minutes compared to 17% pre-intervention. Post-intervention, there were no ICU admissions or
mortalities, and the overall average LOS improved by 26.68%. The average LOS after the
intervention was 5.8 days compared to 7.91 days, pre-intervention. The total average TTA preintervention was 6.61 hours, compared to 1.13 hours, post-intervention. That is an 82.9%
improvement in TTA just by educating staff nurses. While the goal of 80% of patients was not
attained, the project was not executed as originally designed. However, the goal of educating at
least 80% of the staff nurses was reached. The results of this QI project support the research that
streamlined processes can improve TTA, and therefore improve patient outcomes.
Phase 5: Dissemination
Internal dissemination will occur by creating an EBP poster (Appendix G) displaying
important details of the project. The poster will discuss the identified problem, relevant data
supporting the need for the change, methods, and outcomes. The poster will be on display in the
break room of each department and discussed by managers at huddles. While the focus of this
project occurred in the ED, the knowledge and practice change are relevant to any department
and interdisciplinary team, as patients can develop FN at any given time while hospitalized.

Developing an initial plan for external dissemination is the second strategy (Institute for
Healthcare Improvement, 2008). The project mentor, the champion, and voluntary ED staff will
be responsible to spread the aim, which is decreasing time to antibiotics in FN patients in the ED.
The target would be all EDs within the healthcare system. The population, stakeholders, and
timeframe would all follow the implementation plan designed for this hospital. The information
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can be communicated using the EBP poster at various events, including grand rounds, poster
presentation days, and system wide committee meetings.
Recommendations
The goal is to administer antibiotics within one hour to all FN patients presenting to the
ED and ultimately roll-out a streamlined pop-up message and order set in the electronic health
record. This pop-up will alert physicians, nurses, and pharmacists that the patient meets criteria
for FN and to initiate prompt treatments with antibiotics. Ideally, the medication rooms in the ED
will be stocked with the most commonly prescribed antibiotics for FN, to expedite
administration. A policy revision emphasizing timely administration of antibiotics according to
the IDSA is another long-term goal. The policy can be reinforced to staff through yearly
competencies.
Key Lessons Learned
Utilizing EBP is an effective strategy to address clinical issues and implement change.
Consistency and follow-up are key to sustainability and ongoing success. Barriers will always be
present but having alternative plans to overcome the issues will still yield positive results,
especially when a framework is followed to create the culture of change. This QI project
encountered numerous barriers and obstacles, but persistency was essential to ensure the change
reached the patients.
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Table 1

Differentiating Quality Improvement and Research Activities Tool
Question

Yes

1. Is the project designed to bring about immediate improvement in
patient care?

X

2. Is the purpose of the project to bring new knowledge to daily practice?

X

3. Is the project designed to sustain the improvement?

X

4. Is the purpose to measure the effect of a process change on delivery of
care?

X

5. Are ﬁndings specific to this hospital?

X

6. Are all patients who participate in the project expected to benefit?

X

7. Is the intervention at least as safe as routine care?

X

8. Will all participants receive at least usual care?

X

9. Do you intend to gather just enough data to learn and complete the
cycle?

X

10. Do you intend to limit the time for data collection in order to
accelerate the rate of improvement?

X

No

11. Is the project intended to test a novel hypothesis or replicate one?

X

12. Does the project involve withholding any usual care?

X

13. Does the project involve testing interventions/practices that are not
usual or standard of care?

X

14. Will any of the 18 identifiers according to the HIPAA Privacy Rule
be included?

X

Note. Adapted from Foster, J. (2013). Differentiating quality improvement and research
activities. Clinical Nurse Specialist, 27(1), 10–3.
https://doi.org/10.1097/NUR.0b013e3182776db5
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Table 2
ED staff nurse experience
_______________________________________
Years of Experience
n=55
_______________________________________
<5 years

37 (67%)

5-15 years

10 (18%)

>20 years
8 (15%)
_______________________________________
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Table 3
Pre-intervention: Process Measure and Outcome Measures
<60mins

60-90mins

Characteristics

90-120mins
n=17 (%)

120-180mins

>180mins

Patients’ TTA

3(17.65%)

3(17.65%)

3(17.65%)

6(35.29%)

2(11.76%)

ICU

0(0%)

0(0%)

2(66.67%)

0(0%)

2(100%)

Mortality

0(0%)

0(0%)

0(0%)

0(0%)

1(50%)

average # (days)
______________________________________________________________________________
LOS
9.67
12.9
10.7
6.54
10.96
Note. Table 3 displays the data that was collected. It breaks down each measurement by a time
range that patients received their first dose of antibiotics within, demonstrating the relationship
between TTA, LOS, ICU admissions, and mortality.
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Table 4
Post-Intervention: Process Measure and Outcome Measures
<60mins

60-90mins

Characteristics

90-120mins
n=17 (%)

120-180mins

>180mins

Patients’ TTA

9(52.94%)

2(11.76%)

0(0%)

1(5.88%)

5(29.41%)

ICU

0(0%)

0(0%)

n/a

0(0%)

0(0%)

Mortality

0(0%)

0(0%)

n/a

0(0%)

0(0%)

average # (days)
______________________________________________________________________________
LOS
3.78
6
n/a
8
9
Note. Table 4 breaks down each measurement by a time range, that patients received their first
dose of antibiotics within, demonstrating the relationship between TTA, LOS, ICU admissions,
and mortality.
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Figure 1
Pre-intervention: Process Measure and Outcome Measures
100
100

90
80

% patients

70
60

66.67

50
50

40

30

35.29

20
10

17.65

0

0

17.65

0

0

17.65

0

0

0

11.76

0
<60 mins

60-90 mins

90-120 mins

120-180 mins

>180 mins

TTA

Patients' TTA

ICU Admission

Mortality

Note. Figure 1 displays the results of the pre-intervention data. It represents the percentage of
patients who received their antibiotics in each timeframe. The ICU admission and mortality rate
percentages, represent the percent from each timeframe. While only 2 patients received
antibiotics in >180 minutes, 2/2 (100%) were admitted to ICU, with a 1/2 (50%) mortality rate.
3/17 patients received antibiotics within 90-120 minutes, 2/3 (66.67%) were admitted to ICU.
n=17, pre-intervention
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Figure 2
Pre-intervention: Relationship between TTA and LOS
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Note. This figure demonstrates the percentage of patients who received their antibiotics within
the indicated timeframe along the bottom axis. The right vertical axis and line represent the
average length of stay for patients who received their first dose of antibiotics within the
respective timeframe.
n=17, pre-intervention
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Figure 3
Post-intervention: Process Measure and Outcome Measures
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Note. This figure displays the results of the post-intervention data. It represents the percentage of
patients who received their antibiotics within each timeframe. The ICU and mortality rates of
every category were 0, except 90-120 minutes, those measurements were not applicable, as no
patients received antibiotics in that category.
n=17, post-intervention
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Figure 4
Post-intervention: Relationship between TTA and LOS
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Note. This figure demonstrates the percentage of patients who received their antibiotics within
the indicated timeframe along the bottom axis. The right vertical axis and line represent the
average LOS for patients who received their first dose of antibiotics within the respective
timeframe.
n=17, post-intervention
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Appendix A
Current RWJ Policy on Neutropenic Fever Management
Robert Wood Johnson University Hospital
Nursing Guidelines: GUIDELINE: Neutropenia: Assessment and Management of Patient with Prolonged
_________________________________________________________________________________

GUIDELINE: Neutropenia: Assessment and Management of Patient with Prolonged

Originally Created:
Date Revised/Reviewed:

05/1977
05/2016; 04/2012

Approved by Group/Committee: CACNP
TITLE:

Guideline: Assessment and Management of Patient with Prolonged Neutropenia

EFFECTIVE DATE: 3/8/2016
TARGET AUDIENCE:
Robert Wood Johnson University Hospital, Inc. and its related campuses, New Brunswick and Somerset
•

All Registered nurses on Adult units

•

All registered nurses in BMSCH

APPROVED BY:

Oncology Leadership, Patient Care Policy

ATTACHMENTS:

N/A

PURPOSE:

To outline the management of the patient requiring prolonged neutropenic precautions.

DEFINITIONS:
Neutropenia – an absolute neutrophil count (ANC) of less than 500 cells/mm3 or one that is expected to
fall below 500 cells/mm3 over the next 48 hours.

Fever – a complication of neutropenia and is defined as a single oral temperature of greater than or equal
to 101°F (38.3°C) or 100.4°F (38°C) sustained over a 1-hour period.
Chemotherapy-induced neutropenia – a common dose-limiting toxicity, can have negative consequences
for a patient with cancer. In addition to increasing the risk of life-threatening infections, neutropenia
commonly leads to chemotherapy dosage reductions and treatment delays, which can alter a patient’s
response to treatment and overall therapy effectiveness.
POLICY:
1.The ANC should be calculated as follows:
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ANC = % Neutrophils x Total WBC

i.100
ii.Or
ANC = Total WBC x (% segs+ % bands)

1.Risk factors include the patient’s age, any pre-existing health conditions, the type of cancer, and
how the bone marrow will be affected by the level of toxicity of the chemotherapy.
2.Other risk factors for febrile neutropenia include:
c.History of myelosuppressive chemotherapy or radiation
d.Low neutrophil count at the beginning of chemotherapy cycle
e.History of febrile neutropenia
f.Pre-existing infection, open wounds, or recent surgery
g.Poor performance status
h.Therapy regimens involving phenothiazines, diuretics, or immunosuppressive agents
i.Renal or hepatic impairment
j.Weakened immune system related to aging
k.Tumor involvement in the bond marrow
PROCEDURE:
I. Infection Control Measures
3.Calculate the ANC to determine whether neutropenia is present because neutropenia can
occur when the total white blood count is within normal range.
4.Patients with an ANC 1,000 or below must be cared for using neutropenic precautions. A
sign can be posted stating “Neutropenic Precautions” on patient’s door to alert staff and visitors.
5.Patients with ANC of 1,000 or less are a priority for transfer to a private room.
a.If a private room is not available, the patient may be in a semi-private room provided
the other patient occupying the room is free of infection.
b.Pediatric patients require a single room when the ANC is less than 500.
c.Hematopoietic stem cell transplant (HSCT) patients should be placed in private rooms.
d.Allogeneic HSCT patients should be placed in rooms with greater than 12 air
exchanges per hour and high-efficiency particulate air filtration.
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1.Perform hand hygiene and put on gloves, as needed, throughout the procedure to follow
standard precautions. Hand hygiene is the most effective means of preventing transmission of
infection. Perform proper hand hygiene whenever caring for the patient with chemotherapy-induced
neutropenia. No specific personal protective equipment is required during the care of a neutropenic
patient.
2.Health care workers and visitors who have an active illness should not enter the patient’s
room or care for the patient unless wearing an appropriate barrier, such as gloves and mask.
3.Gowning and gloving are not required for all persons entering the patient’s room provided
the patient does not have drug-resistant microorganisms, [e.g., vancomycin resistant enterococcus
(VRE), Methicillin-Resistant Staphylococcus Aureus (MRSA)].

4.If the patient is positive for drug-resistant microorganism, gowning and gloving will be
required. Gown and gloves must be disposed of before leaving the room. Hands should be washed
both before putting gloves on and after removing gloves.
5.A mask should be worn by all patients with an ANC less than 1,000 when outside his/her
room (e.g., in hall or during transport to other areas of the hospital).
I.Supportive Data
6.Due to the decreased ability to defend against infection, all subtle signs of infection must be
observed for and acted upon. A single oral temperature of greater than or equal to 101◦F (38.3◦C) or
a temperature of 100.4◦F (38◦C) sustained over a 1-hour period in a neutropenic patient is considered
an emergency and must be acted upon accordingly.

e.Review all laboratory data from the patient’s medical record. Collect information
needed to calculate the ANC.
f.Obtain the patient’s weight and vital signs, including pulse oximetry, to serve as a
baseline and to monitor for signs of infection, such as fever, tachycardia, and hypotension. If the
patient has a fever, notify practitioner and perform interventions as ordered.
g.Ask the patient whether he has had contact with anyone who has recently had an illness,
or if he has traveled recently, has had any contact with pets or other types of animals, or has recently
received blood products.
h.Assess the patient’s general appearance and check for any changes in mental status.
i.Ask the patient whether he has a history of headaches or seizures.
j.Auscultate the lungs for adventitious breath sounds, and assess for dyspnea.
k.Ask the patient whether he has a cough or whether it’s productive. If the cough is
productive, ask the patient to describe quantity, quality, and color of sputum. Collect a sample, if
indicated.
l.Perform an abdominal assessment and ask the patient whether he has diarrhea or
abdominal pain. Include a thorough examination of the oral cavity to assess for signs and symptoms
of oral mucositis.
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m.Ask the patient whether he has pain or burning upon urination, and inspect his urine
for cloudiness or hematuria.
n.Check sites of indwelling devices, if present, for pain, redness, discharge, or swelling,
which may indicate infection.
o.Monitor and assess the patient’s skin. Clean and protect wounds as needed.
I.Interventions/Protective Care
7.Aseptic Technique: Use strict aseptic technique when performing all invasive procedures
or when manipulating any invasive tubing (bladder, biliary, intestinal, tracheal, abdominal, pleural,
mediastinal, venous or arterial).
8.Perianal Care: Avoid use of suppositories, enemas, rectal thermometers, indwelling urinary
catheters, douches and tampons.
9.Hygiene: Provide meticulous total body hygiene per hospital guidelines with particular
attention to axilla, groin and skin folds. Restrict use of occlusive deodorant (e.g., antiperspirants).
10.Oral Care: Provide or encourage mouth care every meal in addition to morning and night.
Use soft toothbrush or toothettes and oral rinses as prescribed by practitioner. Dentures should only
be worn when necessary, such as eating or talking. Dentures must be cleaned each time they are
removed from the mouth.
11.Foot Care: Asses feet and toes, particularly toes nails.
12.Treatment: Avoid elective subcutaneous or intramuscular injections and any other
invasive procedure when possible.
13.Diet: Patient teaching regarding diet choices while neutropenic must be provided by nurse
or dietician. A neutropenic diet includes cooked foods, and fruits and vegetables that can be washed
and peeled are also allowed. Unpasteurized milk and cheeses, spices such as pepper, and rare meat,
sushi, sashimi and other undercooked or raw eggs, meat, poultry and seafood are to be avoided.
14.Environmental Considerations: Change the water in pitchers, denture cups, and nebulizers
as least once per day. Don’t allow plants and fresh or dried flowers in the patient’s room.
15.Equipment: When performing assessments use disposable equipment such as single use
thermometer and disposable stethoscopes. Non-disposable items must be cleaned with the
appropriate cleaning solution prior to use.

I.Patient/Family Teaching
16.The multidisciplinary team in collaboration with the patient and his family needs to take
precautions to protect the patient from infection by following various infection-prevention practices.
17.Critical to teach the patient and his family evidence-based practices that support hand
hygiene, dietary management, environmental management, and medication use to prevent a lifethreatening infection.
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18.Instruct the patient to avoid people who have colds or other contagious illnesses and
people who have received a live vaccine within the past 30 days and to wear a surgical mask to
protect him from potential organisms.
19.Advise the patient to consider obtaining the pneumonia and influenza vaccines but to not
receive any live vaccinations unless directed by the Licensed Independent Practitioner (LIP).
20.The patient should report immediately to his practitioner a temperature greater than
100.4◦F (38◦C), shaking, chills, painful urination, difficulty breathing, shortness of breath, a
productive cough or chest congestion, and any pain.
21.Instruct the patient to wash his hands frequently with soap and water to protect against the
transmission of harmful organisms.
22.Recommend that he protect his skin from cuts and burns. If there are any breaks in the
skin, he should wash the area with soap and water immediately.
23.Instruct him to bathe every day and to perform oral hygiene at least 3 times per day.
24.Teach the patient to eat thoroughly cooked meats and to avoid luncheon meats, raw eggs
and seafood. Washed, uncooked raw fruits and vegetable are safe. Instruct the patient to choose
restaurants where he knows that the food is fresh and properly cooked and to avoid sharing eating
utensils with other people because this can spread germs.
25.Instruct the patient to avoid contact with reptiles, fish, birds, pets, and farm animals (this
includes avoiding any contact with saliva, feces, urine, litter box contents and barns).

26.Avoid exposure to fresh or dried plants and any areas where the soil has been recently
plowed or overturned.

DOCUMENTATION:
1.Document the patient’s vital signs and your other assessment findings in Electronic Medical
Record (EMR).
2.Record all interventions and the patient’s response to your interventions.
3.Document all teachings with patient and family and their comprehension of your teaching in the
plan of care. Include Infection. Risk/Actual and Neutropenia in the plan of care.
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Appendix B
Table B1. CINAHL Complete Search Terms and Search Results
Search Terms

Number of
hits

Number of title
& abstract
reviewed

Number of fulltext articles
reviewed

Number of
articles selected
for this review
without
duplicates

neutropenic fever or
febrile neutropenia and
antibiotics

69

13

5

5

neutropenic fever or
febrile neutropenia and
length of stay

8

2

2

0
(2 duplicates)

neutropenic fever or
febrile neutropenia and
mortality

23

4

1

0
(1 duplicate)

neutropenic fever or
febrile neutropenia and
antibiotic timing

1

1

1

1
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Table B2. Cochrane Database of Systematic Reviews Complete Search Terms and Search
Results
Search Terms

Number of hits Number of title
& abstract
reviewed

Number of fulltext articles
reviewed

Number of
articles selected
for this review
without
duplicates

neutropenic fever or
febrile neutropenia and
antibiotics

6

0

0

0

neutropenic fever or
febrile neutropenia and
length of stay

2

0

0

0

neutropenic fever or
febrile neutropenia and
mortality

4

0

0

0

neutropenic fever or
febrile neutropenia and
antibiotic timing

0

0

0

0
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Table B3. MEDLINE Search Terms and Search Results
Search Terms

Number of hits Number of title
& abstract
reviewed

Number of fulltext articles
reviewed

Number of
articles selected
for this review
without
duplicates

neutropenic fever or
febrile neutropenia and
antibiotics

136

14

7

2
(5 duplicates)

neutropenic fever or
febrile neutropenia and
length of stay

1

1

1

0
(1 duplicate)

neutropenic fever or
febrile neutropenia and
mortality

2

2

2

0
(2 duplicates)

neutropenic fever or
febrile neutropenia and
antibiotic timing

4

3

3

0
(3 duplicates)
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Table B4. Proquest-Nursing and Allied Health Database Search Terms and Results
Search Terms

Number of hits Number of title
& abstract
reviewed

Number of fulltext articles
reviewed

Number of
articles selected
for this review
without
duplicates

neutropenic fever or
febrile neutropenia and
antibiotics

144

3

1

0
(1 duplicate)

neutropenic fever or
febrile neutropenia and
length of stay

37

4

3

1
(2 duplicates)

neutropenic fever or
febrile neutropenia and
mortality

22

4

4

2
(2 duplicates)

neutropenic fever or
febrile neutropenia and
antibiotic timing

26

1

1

0
(1 duplicate)
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Appendix C
Evidence Summary Table
Article number

1

First author
year
Ali
(2015)

Purpose

To identify whether the gold
standard time of 1 hour for the
administration of antibiotics
was being met in the ED

Evidence type, level of
evidence
Audit of QI study, Level VI

Sample, setting

81 cancer patients presented to
ED between January 2013 and
April 2013 with features of
febrile neutropenia

“Door to needle” time
(administering antibiotics
within the target range of 1
hour or less)

32 females, 49 males

Additionally, looked at when
delays occurred (i.e., weekend,
weekday)

37 patients were pediatrics
(<15 years old)
2

Peyrony (2020)

To investigate the effect of
antibiotic timing and
appropriateness on outcomes in
patients with febrile
neutropenia

Retrospective, Level V

Major Variables Study and their
Definitions

Between January 2016 and
December 2017 in a Paris,
France ED

The effect of the time to
antibiotic initiation on ICU
admission or mortality

How major variables were
measured
Audit of charts during time period
based on ICD-9 code

Findings that help answer question

Overall median of antibiotic
administration was 45 minutes
Pediatric patients received antibiotics
faster due to “red alert” policy

Logistic regression analyses

Median time to IV antibiotics in ED was
66 minutes

249 patients with a median age
of 60

Worth to practice/project, quality
of evidence
Medium quality of evidence since
this was an audit and phase 1 of a
study in this Pakistan hospital,
however; the hospital has a
current policy specific to febrile
neutropenic guidelines

This study did not disprove or
prove that timing of antibiotics
reduces complications in febrile
neutropenic patients.
Medium quality evidence
Limitation: patients were not on
appropriate antibiotics

3

Perron (2014)

To determine time-to-antibiotic
administration in patients with
febrile neutropenia, and its
relationship with length of
hospital stay, ICU monitoring,
and mortality

Retrospective cohort, Level V

105 adult cancer patients with a
diagnosis of febrile neutropenia
at a tertiary care hospital
between January 2010 to
December 2011

Time to antibiotics (measured
from time of ED registration
until time of first dose)
Length of hospital stay
ICU admission

Data was collected based on ICD
code for admission of febrile
neutropenia and a multivariate
regression analysis was performed
to assess the relationship between
time-to-antibiotic administration
and various outcome variables

Positive relationship between delay in
antibiotic administration and longer
length of hospitalization.
1 hour delay resulted in an 8-hour
increase in length of stay

Hospital mortality

Common reasons for delays are
antibiotics are prescribed by
doctors, but administration is
delayed, prolonged time to
assessment by staff, lack of
awareness of neutropenic fever,
failure of ED to stock appropriate
medications, and lack of distinct
protocol for febrile neutropenia
A decrease is noted when order sets
are utilized or when ED initiatives
are taken to improve triage
High quality of evidence

4

Meisenberg
(2014)

To identify areas of needed
improvement and to design
performance improvement
steps to comply with the
guidelines from the Infectious
Diseases Society of America
for antibiotic initiation timing

Evidence based, quality
improvement project, Level VI

Retrospectively analyzed 18
months that included 69 adult
cancer patients with febrile
neutropenia in the ED of an
acute care facility

Time to antibiotic administration

A multidisciplinary task force was
created to perform mixed
methodology analysis of the
management of febrile
neutropenia and assign an
acceptable time limit to each step
involved leading up to the
administration of antibiotics

Educate ED staff and providers about the
need for urgency

Medium quality of evidence worth
using for practice

Educate ED providers on appropriate
antimicrobial choices based on IDSA
guidelines

A streamlined process improved
timing

Institute new laboratory practice for rapid
release of CBC
Update standardized order sets
Have profiled doses stocked in ED
Ongoing monthly review of time to
antibiotics in ED and follow up with staff
when not meeting standards

45
Article number

5

First author
year
Best
(2011)

Purpose

Evidence type, level of
evidence

To evaluate the impact of the
implementation of a
standardized order set on the
time interval in initiation of
antibiotic therapy for adult
patients with cancer and febrile
neutropenia

Evidence based practice change,
Level VI

Sample, setting

Oncology unit of an urban
hospital in the southeastern US
Adult patients with cancer and
febrile neutropenia admitted 6
months prior (n=30) or during
the 3 months following (n=23)
implementation of the order set

Major Variables Study and their
Definitions
Time interval in initiation of
antibiotic therapy

How major variables were
measured

Findings that help answer question

Literature regarding febrile
neutropenia, use of order sets, and
change process was reviewed

Order sets decreased time to antibiotics by
71% in the ED

Retrospective and concurrent
chart review was conducted for
adult patients admitted with
febrile neutropenia
Time intervals were analyzed
using SPSS software

Order set usage, staff education, and
placement of the antibiotics in the
machines in the ED reduce time intervals
for initial antibiotic therapy

Worth to practice/project, quality
of evidence
Medium quality of evidence worth
to practice
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Appendix D
Level of Evidence Synthesis Table
Article Number

1

2

3

X

X

4

5

X

X

Level I: Systematic review or meta-analysis
Level II: Randomized controlled trial
Level III: Controlled trial without randomization
Level IV: Case-control or cohort study
Level V: Systematic review of qualitative or
descriptive studies
Level VI: Qualitative or descriptive study, CPG,
Lit Review, QI or EBP project
Level VII: Expert opinion

X
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Appendix E
Pre-test/Post-test Questions
Directions: Please circle one answer choice for the following questions.
1. When evaluating a neutropenic cancer patient with a fever, in addition to a complete
history and physical examination, special attention should be given to which of the
potential sites of infection?
A.
B.
C.
D.
E.

Skin
Mouth
Perianal region
Intravenous catheter exit site
All of the above

2. Neutropenia is characterized by a decrease in neutrophils and thrombocytes. True or
False?
True
False
3. Features of neutropenic fever include:
A.
B.
C.
D.

Single oral temperature of greater than or equal to 101F
Sustained temperature of 100.4F for one hour
Absolute neutrophil count of less than 1,500 cells/microliter
All of the above

4. You are a member of the interdisciplinary team in the emergency room caring for a
patient who comes in with febrile neutropenia. You should do all of the following except:
A.
B.
C.
D.

Draw blood cultures after starting IV antibiotics
Collect urine for urinalysis and culture
Ensure that a chest x-ray is ordered
Ensure that IV antibiotics are ordered

5. In neutropenic patients, the Infectious Diseases Society of America has identified the
single most important determining factor of outcomes is the timing of antibiotic
administration. The gold standard to deliver antibiotics is:
A.
B.
C.
D.

60 minutes
30 minutes
10 minutes
90 minutes
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6. All of the following are negative outcomes of neutropenia except:
A.
B.
C.
D.

Increased costs
Hospitalization
Better response to chemotherapy
Death

7. Neutropenic patients must be placed in private rooms. True or False?
True
False
8. How do you calculate Absolute Neutrophil Count (ANC)?
A. ANC = (%segs - %bands) x WBC
B. ANC = (%segs + %bands) x WBC
C. ANC = (%segs + %bands)/WBC
D. ANC = (%segs - %bands)/WBC
9. Hypotension, an indicator for sepsis, is an important symptom for neutropenic patients.
True or False?
True
False
10. It is difficult to identify the signs and symptoms of infection in patients with neutropenia.
True or False?
True
False

Answers:
1. E
2. False
3. D
4. A
5. A
6. C
7. True
8. B
9. True
10. True
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Appendix F
Institutional Review Board Exempt Status
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Appendix G
DNP Project Poste
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